Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Hunter

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Radiation Oncology (London, England)|November 5, 2021
Gastrointestinal and genitourinary toxicity profiles of metformin versus placebo in men with prostate cancer receiving prostate radiotherapy: interim toxicity results of a double-blinded, multicenter, phase II randomized controlled trialJulian O Kim, Megan O McDonald, Aldrich Ong, et al.
Current Oncology (Toronto, Ont.)|July 25, 2022
Do Sustainable Palliative Single Fraction Radiotherapy Practices Proliferate or Perish 2 Years after a Knowledge Translation Campaign?Shaheer Shahhat, Nikesh Hanumanthappa, Youn Tae Chung, et al.
International Journal of Radiation Oncology, Biology, Physics|July 30, 2022
Metformin for Prevention of Anthropometric and Metabolic Complications of Androgen Deprivation Therapy in Prostate Cancer Patients Receiving Radical Radiotherapy: A Phase II Randomized Controlled TrialNawaid Usmani, Sunita Ghosh, Karan P Sanghera, et al.
Journal of Pain Research|February 10, 2025
The American Society of Pain and Neuroscience (ASPN) Guidelines and Consensus on the Definition, Current Evidence, Clinical Use and Future Applications for Physiologic Closed-Loop Controlled Neuromodulation in Chronic Pain: A NEURON Group ProjectJason E Pope, Timothy Ray Deer, Dawood Sayed, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Radiation Oncology (London, England)|November 5, 2021
Gastrointestinal and genitourinary toxicity profiles of metformin versus placebo in men with prostate cancer receiving prostate radiotherapy: interim toxicity results of a double-blinded, multicenter, phase II randomized controlled trialJulian O Kim, Megan O McDonald, Aldrich Ong, et al.
Current Oncology (Toronto, Ont.)|July 25, 2022
Do Sustainable Palliative Single Fraction Radiotherapy Practices Proliferate or Perish 2 Years after a Knowledge Translation Campaign?Shaheer Shahhat, Nikesh Hanumanthappa, Youn Tae Chung, et al.
International Journal of Radiation Oncology, Biology, Physics|July 30, 2022
Metformin for Prevention of Anthropometric and Metabolic Complications of Androgen Deprivation Therapy in Prostate Cancer Patients Receiving Radical Radiotherapy: A Phase II Randomized Controlled TrialNawaid Usmani, Sunita Ghosh, Karan P Sanghera, et al.
Journal of Pain Research|February 10, 2025
The American Society of Pain and Neuroscience (ASPN) Guidelines and Consensus on the Definition, Current Evidence, Clinical Use and Future Applications for Physiologic Closed-Loop Controlled Neuromodulation in Chronic Pain: A NEURON Group ProjectJason E Pope, Timothy Ray Deer, Dawood Sayed, et al.
Pageof 4